Official Publication of the Society for Laboratory Automation and Screening
This message contains images. If you don't see images, click here to view.
Advertise in this news brief.


Text version   RSS   Subscribe   Unsubscribe   Archive   Media Kit September 13, 2017    SLAS2018    Moving? New job? Let SLAS know.      







SLAS Grant Winner Julea Vlassakis: Fearless in the Face of Anything New and Unexplored
SLAS     Share    Share on FacebookTwitterShare on LinkedinE-mail article
Discover the drive and desire of the University of California, Berkeley student that led to her $100,000 SLAS Graduate Education Fellowship Grant award. Vlassakis' research is to design and optimize a method for delivery of F-actin stabilization lysis buffer for high-throughput lysis and electrophoresis of G-actin.

She plans to design a novel functional material for high-throughput, in-hydrogel detection of F- and G-actin from single cells, as well as conduct assay validation and application in a high-throughput, whole-genome screen to determine genes that protect actin filament stability.

Applications for the 2018 SLAS Graduate Education Fellowship Grant are due Dec. 11, 2017. Read more about Vlassakis, her work and the SLAS grant in the SLAS Electronic Laboratory Neighborhood e-zine feature article.


Promote Your Published Paper with a Video Abstract on YouTube
SLAS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Video abstracts require relatively little effort or technical expertise and are a compelling way to boost awareness, readership and citations.

Authors today can have a tremendous impact on how their published papers are discovered, recognized and used throughout the scientific community. Learn how with these instructions and helpful hints.

Last Chance to Register for SLAS Europe High-Content Screening Conference
SLAS     Share    Share on FacebookTwitterShare on LinkedinE-mail article
"Droplet-Microarray – A Miniaturized Platform for High-Throughput Screenings," "High-Content Phenotypic Screening Using Disease Relevant, Human, Primary Cells – Identifying and Profiling Diverse Compounds for Cardiac Regeneration," "Exploring Toxicity Profiling for Drug Screening using Deep Learning Strategies" and "Fishing Out New Drugs" are just four of the presentations at the Sept. 19-20 conference in Madrid, Spain.

Participants represent leading-edge institutions including AstraZeneca, Beatson Institute, Ecole Polytechnique, FIMM/University of Helsinki, GSK, Heidelberg University, Johnson & Johnson and King’s College London. On Thursday, Sept. 21, the annual Spanish Drug Discovery Network meeting is being held at the same venue.


Promoted by

Upcoming SLAS Webinars
SLAS     Share    Share on FacebookTwitterShare on LinkedinE-mail article
Sept. 26
3-Dimensional Assays: What Must Be Done for Setting Up and Validating for Downstream Microplate Reader and Imaging Applications
Brad Larson, BioTek Instruments;
Mark Rothenberg, Corning Life Sciences
FREE for SLAS members and non-members alike!
(Related: Join SLAS Past President Richard Eglen for a Corning Life Sciences webinar on Sept. 22.)

Oct. 17
Detecting Small Molecule Non-Covalent Binders Utilizing SAMDI and the Bruker MALDI-TOF – Proof of Concept for a New Screening Format
Erica C. VanderPorten, Genentech senior scientific researcher

Watch SLAS2018 Keynote Speaker Tomorrow, Sept. 14
SLAS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
On Thursday, Sept. 14, 6 p.m. ET, view a live webcast of the 27th 'First Annual' Ig Nobel Prize Ceremony in the Sanders Theater at Harvard University. The Ig Nobel Awards celebrate the unusual, honor the imaginative and spur people's interest in science, medicine and technology. For example, the 2016 prize for biology went jointly to Charles Foster for living in the wild as, at different times, a badger, an otter, a deer, a fox and a bird; and to Thomas Thwaites, for creating prosthetic extensions of his limbs that allowed him to move in the manner of, and spend time roaming hills in the company of, goats.

Winners are not notified in advance; they learn of their honor at the ceremony. Ig Nobel Award presenter and co-founder Marc Abrahams is the SLAS2018 closing keynote speaker.

Reliably screen CRISPR modified lines

Keep your CRISPR/Cas gene editing workflow moving smoothly with fast and reliable detection of positive clones. The AccuCleave™ T7CE Kit uses an optimized heteroduplex cleavage assay to quickly identify and characterize CRISPR induced modifications with fast and reliable detection on the Fragment Analyzer™ Automated CE System from Advanced Analytical.

Who's Talking About Your Research?
SLAS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
People today share, discuss, rate, recommend, review and read published research online in real-time. Altmetric tracks a range of sources to capture and collate this activity, helping authors monitor and understand the immediate impact of their publications.

To benefit SLAS journal authors and readers, Altmetric scoring is now built into SLAS Discovery and SLAS Technology online functionality.

Thank You SLAS2018 Sponsors!
SLAS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Companies are quickly joining forces with SLAS as key sponsors of SLAS2018, Feb. 3-7, San Diego. Topping the list as the event's premier sponsor is Hamilton Company with Artel as a diamond sponsor and platinum sponsors Hamamatsu Photonics, Labcyte, TECAN and ThermoFisher Scientific.

View the complete list of industry leaders who support SLAS2018 as sponsors and find out more about how SLAS2018 sponsorships can help companies tell their stories to world leaders in life sciences discovery and technology.



Researchers Review the Clinical Potential of Senolytic Drugs on Aging
Bioscience Technology    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers are moving closer to realizing the clinical potential of drugs that have previously been shown to support healthy aging in animals. In a review article published online in the Journal of the American Geriatrics Society, Mayo Clinic aging experts say that, if proven to be effective and safe in humans, these drugs could be "transformative" by preventing or delaying chronic conditions as a group instead of one at a time. More

Enhanced Protein Analysis Could Help Early Disease Detection    Share    Share on FacebookTwitterShare on LinkedinE-mail article
People could start receiving life-saving treatment for cancer and other diseases much earlier with the help of a new method to analyze blood proteins. A paper by researchers at Pacific Northwest National Laboratory describes a new way to prepare and analyze blood samples that significantly improves researchers' ability to detect proteins that exist in very low concentrations — as little as 10 picograms per milliliter of blood. More

Sponsored Content

Technique Pinpoints Active Sites on Catalyst Surfaces
Chemical & Engineering News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Many industrial processes use solid catalysts to accelerate chemical reactions in gases or liquids. The activity of these heterogeneous catalysts often varies considerably from site to site across their surfaces. If scientists were able to identify highly reactive sites precisely, they could improve the catalysts by redesigning them to include more of those sites. More

Dispersion and Halogen-Bonding Interactions: Binding of the Axial Conformers of Monohalo- and (±)-trans-1,2-Dihalocyclohexanes in Enantiopure Alleno-Acetylenic Cages
Journal of the American Chemical Society    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Enantiopure alleno-acetylenic cage (AAC) receptors with a resorcin[4]arene scaffold, from which four homochiral alleno-acetylenes converge to shape a cavity closed by a four-fold OH-hydrogen-bonding array, form a highly ordered porous network in the solid state. They enable the complexation and co-crystallization of otherwise non-crystalline small molecules. More

KMC Systems Engineering & Manufacturing

KMC Systems is a leading provider of engineering services and contract manufacturing for the development, design and production of medical and life sciences instrumentation. We specialize in developing mechanized processes for tightly controlled and highly automated systems and manufacturing complex, highly-regulated instruments for the clinical environment.

Clinical Trials Often Unregistered, Unpublished
Lab Manager    Share    Share on FacebookTwitterShare on LinkedinE-mail article
An analysis of more than 100 clinical trials found that they were often unregistered, unpublished and had discrepancies in the reporting of primary outcomes, according to a study published by JAMA. The study is being released to coincide with its presentation at the Eighth International Congress on Peer Review and Scientific Publication. A major aim of trial registration is to help identify and deter the selective reporting of outcomes based on the results. More

Nondestructive Tissue Analysis for ex Vivo and in Vivo Cancer Diagnosis Using a Handheld Mass Spectrometry System
Science Magazine    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Although a surgeon's goal is to remove cancer in its entirety during excision surgery, achieving negative margins (absence of cancer cells at the outer edge of the excised tumor specimen) can be challenging. To facilitate intraoperative diagnosis, Zhang et al. developed a handheld pen-like device that rapidly identifies the molecular profile of tissues using a small volume water droplet and mass spectrometry analysis. More

The Turbulent Healing Powers of Plasma
Science Daily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers are starting to discover the curing powers of plasma — bringing the ion-based form of matter into medical realms. A kind of plasma called non-equilibrium atmospheric pressure plasma can help heal wounds, destroy cancer cells and kill harmful bacteria. The jets of plasma that doctors might use, however, often become turbulent with the direction and velocity changing dramatically. More

Cancer Immunotherapy May Be Improved If Tregs Are Deftly Impaired
Genetic Engineering & Biotechnology News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The balancing act that is cancer immunotherapy requires that the body's antitumor response be given a boost, but not too much of a boost. For example, simply getting rid of Tregs, the regulatory T cells that moderate the immune system’s attack on cancer, would be risky. Such a rash act might precipitate a dangerous autoimmune reaction. An alternative, less extreme approach would be to inhibit Tregs while keeping them around. More


Software Product Manager
Labcyte, Inc.
US – CA – San Jose

Research Postdoctorate Fellow
Baylor Scott & White Health
US – TX - Waco

Senior Director, Global Medical Information
US – IL – Chicago

Search Jobs at SLAS Career Connections



SLAS Point-to-Point
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Dennis Hall, Executive Editor, 469.420.2656   
Contribute news

This edition of SLAS Point-to-Point was sent to ##Email##. To unsubscribe from receiving SLAS Point-to-Point, click here. To unsubscribe from all SLAS e-mail communications, please click here. Did someone forward this edition to you? Subscribe here — it's free!

SLAS Terms of Use Policy

MultiView Privacy Policy 

Recent issues

Sept. 6, 2017
Aug. 30, 2017
Aug. 23, 2017
Aug. 16, 2017

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063